Enhancing hepatic fatty acid oxidation as a strategy for reversing metabolic disorders programmed by maternal undernutrition during gestation

dc.contributor.author
Torrens, Juana María
dc.contributor.author
Orellana Gavaldà, Josep Maria
dc.contributor.author
Palou, Mariona
dc.contributor.author
Sánchez, Juana
dc.contributor.author
Herrero Rodríguez, Laura
dc.contributor.author
Picó, Catalina
dc.contributor.author
Serra i Cucurull, Dolors
dc.contributor.author
Palou Oliver, Andreu
dc.date.issued
2014-10-24T14:34:36Z
dc.date.issued
2014-10-24T14:34:36Z
dc.date.issued
2014-05
dc.date.issued
2014-10-24T14:34:36Z
dc.identifier
1015-8987
dc.identifier
https://hdl.handle.net/2445/59013
dc.identifier
637431
dc.description.abstract
Background/Aims: Moderate maternal calorie-restriction during gestation programmes offspring for a major propensity to develop metabolic alterations in adulthood. We aimed to assess whether increased hepatic fatty-acid oxidation (FAO), at early ages, by gene transfer of Cpt1am (active mutant of carnitine palmitoyltransferase-1a), may be a strategy for reversing metabolic disturbances associated to maternal calorie-restriction during gestation in rats. Methods: AAV-Gfp (control) and AAV-Cpt1am vectors were administered by tail vein injection in 18-day-old control-pups and the offspring of 20% calorie-restricted rats during gestation (CR). After weaning, animals were fed with normal-fat diet. At the age of 4 months, they were moved to HF-diet and sacrificed at the age of 6 months to collect tissues. Locomotive activity, energy expenditure and blood pressure were measured. Results: Under HF-diet, CR-animals showed higher HOMA-IR, adipocyte diameter and hepatic triglyceride accumulation than controls; these alterations were reverted in Cpt1am-injected animals. In liver, this treatment ameliorated inflammatory state, decreased expression of lipogenesis-related genes and partially restored the decreased expression of leptin-receptor occurring in CR-animals. Treatment also reverted the decreased energy expenditure and the increased blood pressure of CR-animals. Conclusion: Increasing hepatic FAO through AAV-Cpt1am injection at juvenile ages prevents some metabolic disorders associated to gestational maternal calorie-restriction.
dc.format
18 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Karger
dc.relation
Reproducció del document publicat a: http://dx.doi.org/10.1159/000358714
dc.relation
Cellular Physiology and Biochemistry, 2014, vol. 33, num. 5, p. 1498-1515
dc.relation
http://dx.doi.org/10.1159/000358714
dc.rights
(c) Karger, 2014
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Bioquímica i Biomedicina Molecular)
dc.subject
Àcids grassos
dc.subject
Dieta hipocalòrica
dc.subject
Fetge
dc.subject
Teràpia genètica
dc.subject
Malnutrició
dc.subject
Complicacions en l'embaràs
dc.subject
Trastorns del metabolisme
dc.subject
Fatty acids
dc.subject
Low-calorie diet
dc.subject
Liver
dc.subject
Gene therapy
dc.subject
Malnutrition
dc.subject
Disorders of metabolism
dc.subject
Complications of pregnancy
dc.title
Enhancing hepatic fatty acid oxidation as a strategy for reversing metabolic disorders programmed by maternal undernutrition during gestation
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.